Compare Aevo (AEVO) vs Bio Protocol (BIO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Aevo vs Bio Protocol — how do they compare? Aevo trades at Rp327.38 (market cap Rp300,53M, Rp54,09M 24h volume), while Bio Protocol trades at Rp496.51 (market cap Rp1,11T, Rp317,28M 24h volume). The key difference: Bio Protocol is far larger — about 3693.5× Aevo's market cap, and Aevo's circulating supply is 917,2M / 1B AEVO (92%) versus 2,2B / 3,3B BIO (68%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Aevo for 87 Days and Bio Protocol for 16 Days on average.
| AEVO | BIO | |
|---|---|---|
Market Cap | Rp300,53M | Rp1,11T |
Volume (24h) | Rp54,09M | Rp317,28M |
Circulating Supply | 917,2M / 1B AEVO (92%) | 2,2B / 3,3B BIO (68%) |
Typical Hold Time | 87 Days | 16 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aevo is currently trading at Rp326.46 with a market cap of Rp301.12 million, showing a bearish technical signal as moving averages indicate selling pressure. The token trades near key support at Rp325, with neutral oscillators suggesting consolidation. No major protocol updates or ecosystem developments were noted recently, keeping fundamental drivers subdued.
Overall outlook remains cautious due to bearish technicals and low liquidity. Key opportunities include potential rebounds from support levels, while risks involve high volatility and limited market depth. Investors should monitor trading volume and on-chain activity for signs of momentum shifts.
Bio Protocol (BIO) trades at Rp503.72 with a market cap of Rp1.12T, showing a bearish technical outlook as indicated by moving averages. The token's circulating supply is 2.2M out of a max 3.3M, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though specific protocol updates are limited. Key support lies at Rp430, with resistance at Rp522.
Overall outlook is cautious due to bearish signals and neutral oscillators. Opportunities include potential rebounds from oversold RSI levels, but risks involve low liquidity and regulatory uncertainties in the crypto space. Investors should monitor network activity and exchange developments closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Aevo
Aevo is the world's first high-performance decentralized options exchange. The exchange runs on a custom EVM roll-up that rolls up to Ethereum. Aevo operates an off-chain orderbook with on-chain settlements. This means that once orders are matched, trades get executed and settled with smart contracts.
Read more on AEVO →About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →
